Immunome Inc.
IMNM—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-2.43
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$6.94M
Net income
$-212.39M
Net margin
-3060.0%
Gross margin
—
Dividends & financials
Immunome Inc. (IMNM) reported revenue of $6.94M and net income of $-212.39M, or $-2.43 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
